Lördag 21 December | 18:51:53 Europe / Stockholm

Kalender

Tid*
2024-02-20 - Bokslutskommuniké 2023
2023-11-07 - Kvartalsrapport 2023-Q3
2023-08-18 - Kvartalsrapport 2023-Q2
2023-04-26 - X-dag ordinarie utdelning BIOS 0.00 SEK
2023-04-25 - Årsstämma
2023-04-25 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-11-15 - Kvartalsrapport 2022-Q3
2022-09-19 - Extra Bolagsstämma 2022
2022-08-31 - Kvartalsrapport 2022-Q2
2022-05-04 - X-dag ordinarie utdelning BIOS 0.00 SEK
2022-05-03 - Årsstämma
2022-05-03 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-09 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-05-04 - Kvartalsrapport 2021-Q1
2021-04-20 - X-dag ordinarie utdelning BIOS 0.00 SEK
2021-04-19 - Årsstämma
2021-02-23 - Bokslutskommuniké 2020
2020-11-05 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-05-08 - X-dag ordinarie utdelning BIOS 0.00 SEK
2020-05-07 - Årsstämma
2020-05-07 - Kvartalsrapport 2020-Q1
2020-02-21 - Bokslutskommuniké 2019
2019-11-05 - Kvartalsrapport 2019-Q3
2019-09-10 - Extra Bolagsstämma 2019
2019-08-13 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning BIOS 0.00 SEK
2019-05-06 - Årsstämma
2019-05-06 - Kvartalsrapport 2019-Q1
2019-02-19 - Bokslutskommuniké 2018
2018-11-06 - Kvartalsrapport 2018-Q3
2018-10-02 - Extra Bolagsstämma 2018
2018-08-24 - Kvartalsrapport 2018-Q2
2018-05-03 - X-dag ordinarie utdelning BIOS 0.00 SEK
2018-05-02 - Årsstämma
2018-05-02 - Kvartalsrapport 2018-Q1
2018-02-26 - Bokslutskommuniké 2017
2017-11-16 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorIndustri
IndustriIndustriprodukter
Bioservo Technologies är ett teknikbolag inriktade mot hälsovårdssektorn. Bolaget utvecklar robotteknologi anpassat för personer som lider utav nedsatt muskelstyrka. Teknologin baseras på den framtagna SEM-teknologin (Soft Extra Muscle), som används för att hantera patientens uthållighet. Ett exempel är bolagets servohandske som är anpassad för personer med nedsatt funktion i händerna. Bolaget grundades 2006 och har sitt huvudkontor i Kista.
2023-12-20 16:00:00

The Companies Registration Office has on 18 December 2023 registered Bioservo Technologies' ("Bioservo") decision on voluntary liquidation and in accordance with the resolution of the extraordinary general meeting on the 14 December 2023 regarding voluntary liquidation under Chapter 25, Section 3 of the Companies Act, appointed Olov Kling, lawyer at Advokatfirman Lindahl as liquidator.

The decision entails that the liquidator replaces the board and the managing director and is assigned to carry out the liquidation. The liquidator will shortly send an application for summons to unknown creditors to the Companies Registration Office.

The liquidator has also initiated the work of trying to find a buyer of Bioservo's business. Interested parties are asked to contact the liquidator for further information.

For more information, please contact
Lawyer Olov Kling, liquidator
Advokatfirman Lindahl KB
Phone: +46 70 210 13 79
olov.kling@lindahl.se

Mikael Wester, Marketing Director, Bioservo Technologies AB
Phone: +468 21 17 10
mikael.wester@bioservo.com

About Bioservo Technologies
Bioservo Technologies AB (publ) is a world leading company in wearable muscle strengthening systems for people in need of extra strength and endurance. All our innovative products and systems are designed to keep people strong, healthy and efficient. The company has a unique global position within soft exoskeleton technology for the hand, both for industrial applications to improve the health for workers and to improve quality of life for people with reduced muscle strength. Bioservo Technologies was founded in 2006 in collaboration between researchers at the Royal Institute of Technology and a doctor at Karolinska University Hospital. Bioservo Technologies is a Swedish public limited company with headquarters in Kista north of Stockholm.

FNCA Sweden AB is the company's Certified Adviser on Nasdaq First North Growth Market.
For more information, please visit www.bioservo.com